Safety, Tolerability and Efficacy of Cael-101 in AL Amyloidosis Patients Treated on a Phase 2, Open-Label, Dose Selection Study to Evaluate the Safety and Tolerability of Cael-101... by Khouri, Jack, Anwer, Faiz, Samaras, Christy J., Mejia Garcia, Alex V., Koc, Omer N., Faiman, Beth M., Hamilton, Kimberly, Mathur, Saveta, Scott, Cynthia, Stefunek, Kathleen, Sgobbo, Josephine, Fada, Sherry, Lewis, Brittany, Shepherd, Kelly, Ahmad, Naqib, Knebusch, Madeleine, Sobolov, Susan B., Jobes, Janet, Daniel, Eileen, Spector, Michael, Valent, Jason

Get full text